Anti-Cancer Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 4
Author(s): Patrick Dallemagne
Affiliation:
Export Options
About this article
Cite this article as:
Dallemagne Patrick, Meet Our Editorial Board Member, Anti-Cancer Agents in Medicinal Chemistry 2015; 15 (4) . https://dx.doi.org/10.2174/187152061504150428140728
DOI https://dx.doi.org/10.2174/187152061504150428140728 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Anti-Cancer Agents in Medicinal Chemistry Nutrients Mediate Bioavailability and Turnover of Proteins in Mammals
Current Protein & Peptide Science Contemporary Progress in the Synthetic Strategies of Imidazole and its Biological Activities
Current Organic Synthesis Body Fluids-Derived Exosomes: Paving the Novel Road to Lung Cancer Diagnosis and Therapy
Anti-Cancer Agents in Medicinal Chemistry Ozone Depletion Explains Global Warming
Current Physical Chemistry Genetic and Modifying Factors that Determine the Risk of Brain Tumors
Central Nervous System Agents in Medicinal Chemistry Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy
Current Pharmaceutical Design The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy
Central Nervous System Agents in Medicinal Chemistry Adopting Network Pharmacology for Cancer Drug Discovery
Current Drug Discovery Technologies Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Docking and QSAR Studies of Aryl-valproic Acid Derivatives to Identify Antiproliferative Agents Targeting the HDAC8
Anti-Cancer Agents in Medicinal Chemistry Photodynamic Therapy For Non-Melanoma Skin Cancers
Current Cancer Therapy Reviews Asialoglycoprotein Receptor-Targeted Radiopharmaceuticals for Measurement of Liver Function
Current Medicinal Chemistry Editorial [Thematic Issue: Structural Characteristics of Short Peptides Solution Recombinant Therapeutic Protein Vaccines]
Protein & Peptide Letters Caspases: Structure-Guided Design of Drugs to Control Cell Death
Mini-Reviews in Medicinal Chemistry Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation
Current Cancer Drug Targets RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry Experimental and Computational Studies on the Inhibition of Acetylcholinesterase by Curcumin and Some of its Derivatives
Current Computer-Aided Drug Design The AmpliChip: A Review of its Analytic and Clinical Validity and Clinical Utility
Current Drug Safety Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design